Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marit Holmqvist

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Aberrant expression of cyclin E in low-risk node negative breast cancerCecilia Ahlin, Bettina Gruhne, Marit Holmqvist, et al.
BMC Cancer|March 12, 2024
Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registrySofia Palmér, Carl Blomqvist, Marit Holmqvist, et al.
Lung Cancer (Amsterdam, Netherlands)|November 25, 2019
Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort studySalomon Tendler, Marit Holmqvist, Gunnar Wagenius, et al.
Acta Oncologica (Stockholm, Sweden)|August 12, 2011
Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden)Cecilia Nilsson, Marit Holmqvist, Leif Bergkvist, et al.
Acta Oncologica (Stockholm, Sweden)|August 23, 2016
A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 yearsCharlotta Wadsten, Hanna Heyman, Marit Holmqvist, et al.
Acta Oncologica (Stockholm, Sweden)|January 25, 2012
Inflammatory cells in node-negative breast cancerBritta Löfdahl, Cecilia Ahlin, Marit Holmqvist, et al.
Breast Cancer Research and Treatment|January 31, 2012
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based studyAnnette Wigertz, Johan Ahlgren, Marit Holmqvist, et al.
Acta Oncologica (Stockholm, Sweden)|March 24, 2010
Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancerAnthoula Koliadi, Cecilia Nilsson, Marit Holmqvist, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 27, 2009
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancerCecilia Ahlin, Wenjing Zhou, Marit Holmqvist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based studyVoralak Vichapat, Hans Garmo, Marit Holmqvist, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Aberrant expression of cyclin E in low-risk node negative breast cancerCecilia Ahlin, Bettina Gruhne, Marit Holmqvist, et al.
BMC Cancer|March 12, 2024
Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registrySofia Palmér, Carl Blomqvist, Marit Holmqvist, et al.
Lung Cancer (Amsterdam, Netherlands)|November 25, 2019
Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort studySalomon Tendler, Marit Holmqvist, Gunnar Wagenius, et al.
Acta Oncologica (Stockholm, Sweden)|August 12, 2011
Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden)Cecilia Nilsson, Marit Holmqvist, Leif Bergkvist, et al.
Acta Oncologica (Stockholm, Sweden)|August 23, 2016
A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 yearsCharlotta Wadsten, Hanna Heyman, Marit Holmqvist, et al.
Acta Oncologica (Stockholm, Sweden)|January 25, 2012
Inflammatory cells in node-negative breast cancerBritta Löfdahl, Cecilia Ahlin, Marit Holmqvist, et al.
Breast Cancer Research and Treatment|January 31, 2012
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based studyAnnette Wigertz, Johan Ahlgren, Marit Holmqvist, et al.
Acta Oncologica (Stockholm, Sweden)|March 24, 2010
Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancerAnthoula Koliadi, Cecilia Nilsson, Marit Holmqvist, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 27, 2009
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancerCecilia Ahlin, Wenjing Zhou, Marit Holmqvist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based studyVoralak Vichapat, Hans Garmo, Marit Holmqvist, et al.
Pageof 2